genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
News
Alzheimers
Stem Cell Model Exposes Astrocytes as Potential Mechanism behind Neurodegeneration
Diabetes
Hybrid “Mini-Insulin” Combines Rapid Action of Cone Snail Venom with Potency…
Synthetic Biology
Engineered Bacteria Demonstrate Antitumor Activity in Mice
Cancer
Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
Translational Medicine
p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiation
Insights
All
Trends for 2020
Bioprocessing
COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
Bioprocessing
Decreasing the Time from Antibody Idea to IND Approval
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Alzheimers
Stem Cell Model Exposes Astrocytes as Potential Mechanism behind Neurodegeneration
Diabetes
Hybrid “Mini-Insulin” Combines Rapid Action of Cone Snail Venom with Potency…
Synthetic Biology
Engineered Bacteria Demonstrate Antitumor Activity in Mice
Cancer
Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
On Demand Webinars
Organoids and Spheroids Help Science See in 3D
Upcoming Webinars
A CRISPR Vision for the Future of Cell Therapy
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
RNAi
RNAi
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
RNAi
Lilly, Dicerna Launch $3.7B+ RNAi Collaboration
RNAi
Alexion, Dicerna Launch $637M+ RNAi Collaboration in Complement-Mediated Diseases
RNAi
ANTIBIOTICS ENHANCE RNAI CAPABILITIES
RNAi
RXi Partners with University of Massachusetts Med School on RNAi Therapeutics for Ocular Disease
RNAi
Scientists Trigger Antitumor Immune Responses Using siRNAs
RNAi
Propeller Twist Blog
RNAi
Autism Genetic Complexity Comes to Light
RNAi
RNA Editing Website
RNAi
Arrowhead Inks Deals that Focus Firm on Nanomedicines
RNAi
SiVirus
RNAi
Alnylam and MIT Advance Research on Systemic Delivery of RNAi Therapeutics...
RNAi
Chemokine Receptor-Targeting siRNA Nanoparticles Used to Reduce Damage in Multiple Disease...
RNAi
MicroRNA Maneuvers Limit Time on Target, Maintain Ace Status
RNAi
Alnylam and Novartis Take RNAi Therapeutics Collaboration into Fifth Year
RNAi
Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification
1
2
3
...
5
Page 1 of 5
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Illustration of chromosome 16 showing the 14 fly counterparts of the 25 human genes located in a deletion on the chromosome that is associated with autism risk. Researchers used RNA interference (RNAi) to the reduce the expression of these genes individually and in tandem to test how the interactions of these genes modulate neurodevelopmental symptoms associated with the deletion. Interactions between genes that either enhance or suppress the affect of reduced expression are shown by red or blue lines. [Girirajan Laboratory/Penn State]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul2_2018_PennState_Chromosome16Ilustration4113701011-324x160.jpg "Autism Genetic Complexity Comes to Light")
